Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,009 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real-world treatment patterns in patients initiating third-line therapy for relapsed or refractory multiple myeloma in Germany, Italy, the United Kingdom, France, and Spain.
Lehne M, Kortüm KM, Ramasamy K, Zamagni E, d'Estrubé T, Zhuleku E, Hanna M, Shukla S, Ghiani M, Maywald U, Wilke T, Kellermann L, Perera S. Lehne M, et al. Among authors: perera s. Eur J Haematol. 2024 May;112(5):701-713. doi: 10.1111/ejh.14161. Epub 2023 Dec 25. Eur J Haematol. 2024. PMID: 38146208
Treatment preferences of patients with relapsed or refractory multiple myeloma in the United States, United Kingdom, Italy, Germany, France, and Spain: results from a discrete choice experiment.
Thomas C, Ailawadhi S, Popat R, Kleinman D, Ross MM, Gorsh B, Mulnick S, O'Neill A, Paka P, Hanna M, Krucien N, Molinari A, Gelhorn HL, Perera S. Thomas C, et al. Among authors: perera s. Front Med (Lausanne). 2023 Nov 23;10:1271657. doi: 10.3389/fmed.2023.1271657. eCollection 2023. Front Med (Lausanne). 2023. PMID: 38076274 Free PMC article.
Efficacy and safety of single-agent belantamab mafodotin versus pomalidomide plus low-dose dexamethasone in patients with relapsed or refractory multiple myeloma (DREAMM-3): a phase 3, open-label, randomised study.
Dimopoulos MA, Hungria VTM, Radinoff A, Delimpasi S, Mikala G, Masszi T, Li J, Capra M, Maiolino A, Pappa V, Chraniuk D, Osipov I, Leleu X, Low M, Matsumoto M, Sule N, Li M, McKeown A, He W, Bright S, Currie B, Perera S, Boyle J, Roy-Ghanta S, Opalinska J, Weisel K. Dimopoulos MA, et al. Among authors: perera s. Lancet Haematol. 2023 Oct;10(10):e801-e812. doi: 10.1016/S2352-3026(23)00243-0. Lancet Haematol. 2023. PMID: 37793771 Clinical Trial.
Elemental Composition of Commercially Available Cannabis Rolling Papers.
Wright D, Jarvie MM, Southwell B, Kincaid C, Westrick J, Perera SS, Edwards D, Cody RB. Wright D, et al. Among authors: perera ss. ACS Omega. 2024 Apr 20;9(17):19020-19030. doi: 10.1021/acsomega.3c09580. eCollection 2024 Apr 30. ACS Omega. 2024. PMID: 38708199 Free PMC article.
Dumbbell neurofibroma in pregnancy: A case report.
Weerasekara P, Chandraratne N, Perera S. Weerasekara P, et al. Among authors: perera s. Int J Gynaecol Obstet. 2024 Apr 26. doi: 10.1002/ijgo.15564. Online ahead of print. Int J Gynaecol Obstet. 2024. PMID: 38666316 No abstract available.
1,009 results